Adrenomimetics
Adrenomimetics, also known as adrenergic agonists, are drugs that stimulate adrenergic receptors in the sympathetic nervous system. They can act directly on adrenergic receptors or indirectly by increasing the availability of endogenous catecholamines.
Classification
- Direct-Acting Adrenomimetics (Bind to receptors and activate them):
- Alpha-Selective:
- Alpha-1: Oxymetazoline, Xylometazoline, Phenylephrine – Primarily used for vasoconstriction (e.g., nasal decongestants).
- Alpha-2: Clonidine – Reduces norepinephrine release, decreasing blood pressure.
- Beta-Selective:
- Beta-1: Dobutamine – Increases heart rate and myocardial contractility.
- Beta-2: Salbutamol, Fenoterol, Salmeterol – Promote bronchodilation for asthma and COPD.
- Non-Selective:
- Epinephrine – Activates both alpha and beta receptors, increasing heart rate, vasoconstriction, and bronchodilation.
- Indirect-Acting Adrenomimetics (Enhance norepinephrine release or inhibit reuptake):
- Amphetamine, Cocaine, Tyramine – Promote norepinephrine release or prevent reuptake, leading to prolonged adrenergic effects.
- MAO inhibitors – Block norepinephrine degradation, increasing its availability.
- Mixed-Acting Adrenomimetics (Both direct and indirect effects):
- Ephedrine – Binds to adrenergic receptors while also promoting norepinephrine release.
Pharmacodynamics
- Alpha-1 Agonists: Cause vasoconstriction by stimulating alpha-1 receptors on vascular smooth muscle, leading to increased blood pressure and reduced nasal congestion.
- Alpha-2 Agonists: Inhibit norepinephrine release via presynaptic alpha-2 receptors, leading to reduced sympathetic outflow, lowered blood pressure, and decreased insulin secretion.
- Beta-1 Agonists: Increase heart rate and myocardial contractility by stimulating beta-1 receptors in the heart.
- Beta-2 Agonists: Induce bronchodilation by relaxing bronchial smooth muscle, which is useful in asthma and COPD.
- Non-Selective Beta Agonists: Activate both beta-1 and beta-2 receptors, leading to increased heart rate and bronchodilation.
- Indirect-Acting Adrenomimetics: Enhance norepinephrine release or inhibit reuptake, leading to prolonged adrenergic stimulation.
- Mixed-Acting Adrenomimetics: Activate adrenergic receptors directly while also promoting norepinephrine release.